Ulf de Faire Selected Research

Ulf de Faire Research Topics

Disease

39	Hypertension (High Blood Pressure) 11/2023 - 01/2001
39	Myocardial Infarction 01/2022 - 03/2002
37	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 03/2002
32	Atherosclerosis 01/2023 - 01/2001
23	Stroke (Strokes) 01/2022 - 03/2002
21	Coronary Disease (Coronary Heart Disease) 01/2022 - 08/2002
20	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2014 - 03/2002
14	Inflammation (Inflammations) 01/2020 - 12/2007
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 09/2002
9	Type 2 Diabetes Mellitus (MODY) 11/2023 - 11/2005
8	Ischemic Stroke 09/2022 - 04/2009
8	Insulin Resistance 10/2016 - 07/2004
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 12/2005
7	Carotid Artery Diseases 01/2021 - 11/2003
5	Diabetes Mellitus 01/2019 - 09/2002
5	Obesity 03/2016 - 11/2004
4	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2010
4	Thrombosis (Thrombus) 01/2014 - 05/2009
4	Rheumatoid Arthritis 06/2012 - 06/2004
3	Overweight 03/2016 - 06/2003
3	Alzheimer Disease (Alzheimer's Disease) 01/2010 - 04/2003
2	Hyperlipidemias (Hyperlipidemia) 11/2023 - 12/2016
2	Atrial Fibrillation 09/2022 - 08/2021
2	Hypercholesterolemia 01/2022 - 01/2005
2	Hyperplasia 01/2020 - 01/2016
2	Heart Failure 01/2019 - 08/2007
2	Neoplasms (Cancer) 01/2019 - 01/2018
2	Unstable Angina 01/2014 - 05/2002
2	Acute Coronary Syndrome 11/2013 - 07/2013
2	Necrosis 09/2013 - 11/2011
2	Vascular Diseases (Vascular Disease) 08/2012 - 08/2003
2	Peripheral Arterial Disease 08/2012 - 01/2005
2	Abdominal Obesity 06/2012 - 08/2007
2	Heart Diseases (Heart Disease) 12/2010 - 01/2007
2	Isolated Systolic Hypertension 03/2005 - 09/2002
2	Albuminuria 02/2005 - 09/2004
2	Left Ventricular Dysfunction 01/2005 - 05/2002

Drug/Important Bio-Agent (IBA)

19	AntibodiesIBA 11/2023 - 01/2001
19	Losartan (Cozaar)FDA LinkGeneric 02/2010 - 03/2002
18	Immunoglobulin M (IgM)IBA 11/2023 - 09/2006
18	Atenolol (Tenormin)FDA LinkGeneric 02/2010 - 03/2002
16	LipidsIBA 01/2023 - 08/2002
16	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2009
15	Triglycerides (Triacylglycerol)IBA 03/2016 - 09/2002
14	Phosphorylcholine (Phosphocholine)IBA 01/2022 - 09/2006
12	Interleukin-6 (Interleukin 6)IBA 09/2022 - 12/2005
12	CholesterolIBA 01/2022 - 04/2005
12	HDL CholesterolIBA 03/2016 - 08/2002
11	oxidized low density lipoproteinIBA 06/2012 - 01/2001
9	Antihypertensive Agents (Antihypertensives)IBA 09/2009 - 03/2002
8	ApolipoproteinsIBA 12/2021 - 09/2002
8	Glucose (Dextrose)FDA LinkGeneric 10/2016 - 11/2004
7	LDL CholesterolIBA 01/2020 - 08/2010
7	LDL Lipoproteins (beta Lipoproteins)IBA 11/2013 - 03/2008
6	Proteins (Proteins, Gene)FDA Link 04/2017 - 08/2010
6	Lipoproteins (Lipoprotein)IBA 11/2013 - 09/2002
6	C-Reactive ProteinIBA 12/2010 - 06/2003
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019 - 03/2012
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 02/2013
5	Insulin (Novolin)FDA Link 11/2017 - 11/2004
5	AutoantibodiesIBA 01/2014 - 11/2003
5	lacidipineIBA 01/2014 - 09/2003
5	HDL LipoproteinsIBA 11/2013 - 06/2009
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2021 - 08/2007
4	InterleukinsIBA 08/2021 - 05/2009
4	Cytokine Receptor gp130IBA 08/2021 - 06/2015
4	Apolipoproteins E (ApoE)IBA 05/2013 - 04/2003
4	Indicators and Reagents (Reagents)IBA 01/2013 - 03/2002
3	Malondialdehyde (Propanedial)IBA 11/2023 - 01/2014
3	Immunoglobulin G (IgG)IBA 11/2023 - 03/2008
3	Interleukin-8 (Interleukin 8)IBA 01/2023 - 03/2014
3	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022 - 01/2014
3	Apolipoproteins B (ApoB)IBA 12/2021 - 08/2012
3	Fibrinogen (Factor I)FDA Link 10/2021 - 08/2002
3	Particulate MatterIBA 01/2021 - 03/2011
3	Apolipoprotein B-100 (Apo B 100)IBA 09/2014 - 03/2008
3	Plasminogen Activator Inhibitor 1IBA 09/2013 - 06/2003
3	Angiotensin Receptor AntagonistsIBA 02/2010 - 09/2005
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 09/2005
2	PhosphatidylserinesIBA 01/2017 - 01/2014
2	AlbuminsIBA 12/2016 - 09/2004
2	Interleukin-5 (Interleukin 5)IBA 05/2016 - 03/2015
2	Proprotein Convertase 9IBA 03/2016 - 06/2012
2	Lipoprotein(a)IBA 03/2016 - 08/2012
2	AdiponectinIBA 08/2015 - 01/2012
2	Hormones (Hormone)IBA 06/2015 - 01/2012
2	CreatinineIBA 01/2015 - 09/2004
2	Messenger RNA (mRNA)IBA 09/2014 - 06/2012
2	25-hydroxyvitamin DIBA 06/2014 - 11/2013
2	hydroxide ionIBA 06/2014 - 11/2013
2	Cardiolipins (Cardiolipin)IBA 01/2014 - 01/2013
2	EpitopesIBA 01/2014 - 06/2004
2	Apolipoprotein C-I (Apolipoprotein C1)IBA 12/2010 - 09/2002
2	Blood Coagulation Factors (Coagulation Factor)IBA 06/2010 - 05/2009
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2010 - 01/2005
2	CytokinesIBA 09/2009 - 01/2001
2	Hemoglobins (Hemoglobin)IBA 06/2009 - 01/2009
2	EnzymesIBA 12/2008 - 08/2007
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2005 - 01/2005

Therapy/Procedure

8	Therapeutics 06/2015 - 12/2003